Drugs that contain Dalbavancin Hydrochloride

1. Drug name - DALVANCE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8143212 ALLERGAN Dalbavancin compositions for treatment of bacterial infections Nov, 2023

(1 year, 1 month from now)

US7119061 ALLERGAN Dalbavancin compositions for treatment of bacterial infections Nov, 2023

(1 year, 1 month from now)

US7115564 ALLERGAN Stable pharmaceutical compositions of dalbavancin and methods of administration Nov, 2023

(1 year, 1 month from now)

US6900175 ALLERGAN Methods of administering dalbavancin for treatment of bacterial infections Dec, 2023

(1 year, 2 months from now)

Treatment: Treatment of bacterial infections using a two-dose regimen of dalbavancin.

Dosage: POWDER;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 500MG BASE/VIAL POWDER;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.